Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Happiness Biotech Acquires Majority Ownership in Fujian Shennong 2021-10-25 20:00
111, Inc. Announces Strategic Partnership with Chugai Pharma China Co., Ltd. to Accelerate Innovations in Chronic Disease Management 2021-10-25 19:00
Meet the Next Resolution in Medicine -- Polaris Biology Releases Starion™, the next-generation mass cytometer 2021-10-23 15:05
I-Mab Expands U.S. Footprint with New R&D Site in San Diego 2021-10-22 20:00
Ping An Good Doctor Unveils Strategic 2.0 Continuum 2021-10-22 17:08
/C O R R E C T I O N -- Nervotec/ 2021-10-22 16:40
2021 Bio-enzyme Application Explorer Summit held in Chengdu 2021-10-22 14:23
Akeso is rapidly advancing the clinical study of the PD-1/CTLA-4 bispecific antibody Cadonilimab combined with TIGIT monoclonal antibody for the teratment of solid tumors 2021-10-22 09:50
Specialised Therapeutics Enters into a New Supply and Distribution Agreement with Incyte to Launch Two New Cancer Therapies, Tafasitamab and Pemigatinib, in Australia, New Zealand and Singapore 2021-10-22 09:00
Kintor Pharma Announces PD-L1/TGF-β dual-targeting antibody (GT90008) Approved for Advanced Solid Tumour Clinical Trial in China 2021-10-21 22:33
NFL Alumni Performance Labs Forms Exclusive Partnership with Nervotec to Deliver Best-in-Class Predictive Vital Sign Analytics 2021-10-21 21:46
Speclipse included in MedTech Outlook rating of top 10 non-invasive device companies 2021-10-21 21:00
Guangzhou Concord Cancer Center Becomes a Designated Hospital of Social Healthcare Insurance 2021-10-21 16:00
Luoxin Pharmaceutical signs licensing agreement with Austria-based Marinomed Biotech AG for Budesolv® Budesonide Nasal Spray 2021-10-21 15:58
A Hypercompact CRISPR Technology Developed by GenKOre is deemed a Potential Game Changer in Gene Therapy. 2021-10-21 09:05
GenFleet Announces First Patient Dosed in Phase Ib/II Trial of TGF-β R1 Inhibitor in Combination with PD-1 Inhibitor in Global Multi-center Research 2021-10-21 08:05
Senhwa Presents Positive Initial Data from Phase 2 Clinical Trial of Silmitasertib (CX-4945) in Moderate COVID-19 Patients At the ISIRV-WHO Conference 2021-10-20 20:52
Bridge Biotherapeutics Announces Initiation of the Phase I Clinical Trial for BBT-401 in China 2021-10-20 07:00
Alterity Therapeutics Announces Expanded ATH434 Phase 2 Clinical Development Program 2021-10-20 05:08
Mandatory Certification for MoCA Cognitive Assessment Now Free for Students, Faculty and Academic Researchers 2021-10-20 01:09
1 195 196 197 198 199 802